Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Interleukin 4")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 3061

  • Page / 123
Export

Selection :

  • and

A localized absence of interleukin-4 triggers periodontal disease activity : a novel hypothesisSHAPIRA, L; VAN DYKE, T. E; HART, T. C et al.Medical hypotheses. 1992, Vol 39, Num 4, pp 319-322, issn 0306-9877Article

Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cellsKAPIOTIS, S; BESEMER, J; BEVEC, D et al.Blood. 1991, Vol 78, Num 2, pp 410-415, issn 0006-4971Article

Association of susceptibility to brucellosis and interleukin-4 promoter polymorphismREZAZADEH, Mehdi; HAJILOOI, Mehrdad; HAIDARI, Mehran et al.Scandinavian journal of infectious diseases. 2006, Vol 38, Num 11-12, pp 1045-1049, issn 0036-5548, 5 p.Article

Both interleukin-4 (IL-4) and IL-4 receptor α signaling contribute to the development of hepatic granulomas with optimal antileishmanial activitySTÄGER, Simona; ALEXANDER, James; CARTER, K. Christine et al.Infection and immunity. 2003, Vol 71, Num 8, pp 4804-4807, issn 0019-9567, 4 p.Article

Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanomaKAWAKAMI, Y; ROSENBERG, S. A; LOTZE, M. T et al.The Journal of experimental medicine. 1988, Vol 168, Num 6, pp 2183-2191, issn 0022-1007Article

Factor XIII-A is involved in the regulation of gene expression in alternatively activated human macrophagesTÖRÖCSIK, Dániel; SZELES, Lajos; PARAGH, György et al.Thrombosis and haemostasis. 2010, Vol 104, Num 4, pp 709-717, issn 0340-6245, 9 p.Article

Development of detection methods for mminant interleukin (IL)-4HOPE, J. C; KWONG, L. S; THOM, M et al.Journal of immunological methods. 2005, Vol 301, Num 1-2, pp 114-123, issn 0022-1759, 10 p.Article

Interleukin-4-Promoted T Helper 2 Responses Enhance Nippostrongylus brasiliensis-Induced Pulmonary PathologyMEARNS, Helen; HORSNELL, William G. C; HOVING, J. Claire et al.Infection and immunity. 2008, Vol 76, Num 12, pp 5535-5542, issn 0019-9567, 8 p.Article

Secondary structure and topology of human interleukin 4 in solutionREDFIELD, C; SMITH, L. J; BOYD, J et al.Biochemistry (Easton). 1991, Vol 30, Num 46, pp 11029-11035, issn 0006-2960Article

Effects of inteleukin-4 and interleukin-6 on the proliferation of CD34+ and CD34- blasts from acute myelogenous leukemiaAKASHI, K; HARADA, M; SHIBUYA, T et al.Blood. 1991, Vol 78, Num 1, pp 197-204, issn 0006-4971Article

IL-4 inhibits superoxide production by human mononuclear phagocytesABRAMSON, S. L; GALLIN, J. I.The Journal of immunology (1950). 1990, Vol 144, Num 2, pp 625-630, issn 0022-1767Article

FGFR-1 regulates angiogenesis through cytokines interleukin-4 and pleiotrophinMAGNUSSON, Peetra U; DIMBERG, Anna; MELLBERG, Sofie et al.Blood. 2007, Vol 110, Num 13, pp 4214-4222, issn 0006-4971, 9 p.Article

Interleukin-4 can be a key positive regulator of inflammatory arthritisOHMURA, Koichiro; NGUYEN, Linh T; LOCKSLEY, Richard M et al.Arthritis and rheumatism. 2005, Vol 52, Num 6, pp 1866-1875, issn 0004-3591, 10 p.Article

Induction of the IL-13 receptor α2-chain by IL-4 and IL-13 in human keratinocytes : involvement of STAT6, ERK and p38 MAPK pathwaysDAVID, Muriel; FORD, Dwayne; BERTOGLIO, Jacques et al.Oncogene (Basingstoke). 2001, Vol 20, Num 46, pp 6660-6668, issn 0950-9232Article

Effects of in vivo administration of interleukin-2 (IL-2) and IL-4, a lone and in combination, on ex vivo human basophil histamine releaseWHITE, M. V; IGARASHI, Y; EMERY, B. E et al.Blood. 1992, Vol 79, Num 6, pp 1491-1495, issn 0006-4971Article

Phase I evaluation of thrice-daily intravenous bolus interleukin-4 in patients with refractory malignancyATKINS, M. B; VACHINO, G; TILG, H. J et al.Journal of clinical oncology. 1992, Vol 10, Num 11, pp 1802-1809, issn 0732-183XArticle

Regulation of interleukin-4 production in human mononuclear cellsHOLTER, W; MAJDIC, O; KALTHOFF, F. S et al.European journal of immunology. 1992, Vol 22, Num 10, pp 2765-2767, issn 0014-2980Article

Pre-clinical toxicity of IL-4 : a model for studying protein therapeuticsDEAN, J. H; CORNACOFF, J. B; BARBOLT, T. A et al.International journal of immunopharmacology. 1992, Vol 14, Num 3, pp 391-397, issn 0192-0561Conference Paper

Functional assessment and partial characterization of [3H](+)-pentazocine binding sites on cells of the immune systemCARR, D. J. J; DEJ COSTA, B. R; RADESCA, L et al.Journal of neuroimmunology. 1991, Vol 35, Num 1-3, pp 153-166, issn 0165-5728Article

Homeostatic action in interleukin-4 on endogenous and recombinant interleukin-2-induced activated killer cell functionBELLO-FERNANDEZ, C; BIRD, C; HESLOP, H. E et al.Blood. 1991, Vol 77, Num 6, pp 1283-1289, issn 0006-4971Article

Alternative activation of macrophages by IL-4 enhances the proteolytic capacity of their phagosomes through synergistic mechanismsBALCE, Dale R; BAOQUAN LI; ALLAN, Euan R. O et al.Blood. 2011, Vol 118, Num 15, pp 4199-4208, issn 0006-4971, 10 p.Article

Interleukin (IL)-4 Induces Leukocyte Infiltration In Vivo by an Indirect MechanismRATTHE, Claude; ENNACIRI, Jamila; GARCES GONCALVES, David M et al.Mediators of inflammation. 2009, Vol 2009, Num 2, issn 0962-9351, 193970.1-193970.10Article

Association between severe respiratory syncytial virus infection and IL13/IL4 haplotypesPUTHOTHU, Beena; KRUEGER, Marcus; FORSTER, Johannes et al.The Journal of infectious diseases. 2006, Vol 193, Num 3, pp 438-441, issn 0022-1899, 4 p.Article

Erythroid progenitors in polycythemia vera demonstrate a different response pattern to IL-4 compared to the normal BFU-E from peripheral bloodDE WOLF, J. T. M; HENDRIKS, D. W; BEENTJES, J. A. M et al.Experimental hematology. 1991, Vol 19, Num 9, pp 888-892, issn 0301-472XArticle

Involvement of cyclic adenosine monophosphate in the interleukin 4 inhibitory effect on interleukin 2-induced lymphokine-activated killer generationBLAY, J.-Y; BRANELLEC, D; ROBINET, E et al.The Journal of clinical investigation. 1990, Vol 85, Num 6, pp 1909-1913, issn 0021-9738Article

  • Page / 123